Crystal Structure of an Anti-meningococcal Subtype P1.4 PorA Antibody Provides Basis for Peptide–Vaccine Design

This publication has 49 references indexed in Scilit:

• Development of vaccines against meningococcal disease
  The Lancet, 2002
• Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine
  Vaccine, 2001
• Prevention of Meningococcal Serogroup B Infections in Children: A Protein‐Based Vaccine Induces Immunologic Memory
  The Journal of Infectious Diseases, 2001
• Immunogenicity and safety of monovalent P1.7h,4 meningococcal outer membrane vesicle vaccine in toddlers: comparison of two vaccination schedules and two vaccine formulations
  Vaccine, 2000
• Bactericidal antibody response toNeisseria meningitidisserogroup B in patients with bacterial meningitis: effect of immunization with an outer membrane protein vaccine
  FEMS Immunology & Medical Microbiology, 2000
• Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2–3 and 7–8 years of age
  Vaccine, 2000
• Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins
  Vaccine, 1999
• New Zealand Epidemic of Meningococcal Disease Identified by a Strain with Phenotype B:4:P1.4
  The Journal of Infectious Diseases, 1998
• The maintenance of strain structure in populations of recombining infectious agents
  Nature Medicine, 1996
• ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITIS
  The Lancet, 1983